PepKon
Pre-clinicalPepkon is a biotech company developing a therapeutic peptide platform in oncology. Its lead candidate is an agonist peptide targeting the TSP-1/CD47 pathway.
Founded
2018
Focus
RNA & Gene Therapy
About
Pepkon is a biotech company developing a therapeutic peptide platform in oncology. Its lead candidate is an agonist peptide targeting the TSP-1/CD47 pathway.
Company Info
TypePrivate
Founded2018
LocationParis, France
StagePre-clinical
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile